1+ day, 6+ hour ago  (528+ words) Nazata Bio, a Dublin-based medtech company, plans to raise "900, 000 in a funding round later this year. The company has developed an innovative app designed to help individuals with high blood pressure more effectively manage their health. Founded in 2021 by Tom…...

9+ hour, 31+ min ago  (70+ words) Tim Shanahan, VP of Ipsen, chair of Bio Pharma Chem. Tim Shanahan, VP for external manufacturing operations at Ipsen, has been elected as chair of Bio Pharma Chem Ireland (BPCI), the Ibec group representing the biopharmaceutical and chemical sectors in…...

1+ day, 3+ hour ago  (693+ words) Bitget Zentalis' Dose Lock Sets 2026 Binary: DENALI Readout Will Decide If $2. 76 Is Justified or a "Buy the Rumor" Trap The core event is straightforward. Zentalis ZNTL+49. 55% selected a 400mg once daily on a 5-days-on, 2-days-off schedule as the dose for its…...

1+ day, 4+ hour ago  (385+ words) Sahm CRISPR's One-Time ANGPTL3 Edit for Lipids Might Change The Case For Investing In CRISPR Therapeutics (CRSP) - CRISPR Therapeutics recently highlighted its expanding gene-editing pipeline, including cardiovascular and metabolic programs such as CTX310 and CTX320, and past participation by senior management in the…...

9+ hour, 13+ min ago  (47+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....

10+ hour ago  (102+ words) Atopic Dermatitis Market (2025) | Eczema, Skincare, Vitamin D, open PR. com Atopic Dermatitis Market (2025) | Eczema, Skincare, Vitamin D, Pipeline Drugs & United States Growth | Top Companies 2026 - LEO Pharma Inc. , Incyte Corporation, Arcutis Biotherapeutics, Inc. , Otsuka Pharmaceutical Co. , Ltd Press release from: Data…...

23+ hour, 56+ min ago  (112+ words) North America held the largest share of the API market in 2024, supported by a well-established pharmaceutical industry, advanced manufacturing infrastructure, and strong regulatory frameworks. The presence of leading pharmaceutical companies, high healthcare expenditure, and rapid adoption of innovative therapies continue…...

10+ hour, 19+ min ago  (615+ words) Equities research analysts at Raymond James Financial began coverage on shares of Milestone Pharmaceuticals (NASDAQ: MIST " Get Free Report) in a report issued on Friday, Market Beat reports. The brokerage set a "strong-buy" rating and a $6. 00 price target on the…...

2+ day, 58+ min ago  (349+ words) Sahm Is Damora Therapeutics" (DMRA) New CEO and Fast Track Status Reframing Its Pipeline Execution Story? - Earlier this week, Damora Therapeutics highlighted recent corporate developments, including the appointment of Jennifer Jarrett as President and CEO and an FDA fast track…...

16+ hour, 40+ min ago  (284+ words) The deal is about one drug: Vykat XR. And the numbers show why Neurocrine NBIX-2. 09% paid a premium for it. This isn't a bet on a pipeline; it's a cash grab on a commercial machine already running. First, the market....